• About us
  • Contact us
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Sunday, November 30, 2025
No Result
View All Result
Dynamic Trades Today
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Top News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Top News
No Result
View All Result
Dynamic Trades Today
No Result
View All Result
Home Investing

Europe bulletin: US-Swiss trade deal, UK tax U-turn, Novo Nordisk shake-up

by DynamicTradesToday
November 15, 2025
in Investing
0
Europe bulletin: US-Swiss trade deal, UK tax U-turn, Novo Nordisk shake-up
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Europe saw a flurry of political and economic developments this week, from a major US–Swiss trade breakthrough to the UK government’s surprise decision to shelve a planned income tax rise.

The BBC found itself in hot water over a misleading edit of a Trump speech, prompting an apology but no payout.

And in corporate news, Novo Nordisk shareholders backed sweeping board changes, solidifying the Foundation’s influence as competition in obesity drugs intensifies.

A glance at the major developments in Europe today.

US-Swiss tariff truce

The US and Switzerland have struck a new trade deal that rolls back tariffs on Swiss imports from 39% to 15%, undoing the steep hikes put in place earlier under the Trump administration.

In return, Switzerland has agreed to pour $200 billion into the US economy by 2028, with a hefty $70 billion coming as soon as next year.

The lower tariff rate brings Switzerland in line with what the US charges EU countries, which should help calm recent trade tensions.

Industries like pharma, luxury goods, and even coffee are expected to benefit from the easing of costs and smoother cross-border business.

The White House is expected to release more details soon, but for now, the agreement already marks a big step forward for US–Swiss trade relations.

Starmer, Reeves scrap tax increase

It looks like Prime Minister Keir Starmer and Finance Minister Rachel Reeves are backing away from plans to raise income tax in the 2025 budget.

The shift comes just weeks before the budget is due, and it’s mainly because the latest fiscal forecasts turned out better than expected, meaning the government isn’t under as much pressure to hike taxes as everyone thought.

For months, people assumed Reeves and Starmer would raise income tax to plug a big hole in the public finances. But worries about how voters might react, plus some rumblings inside the Labour Party, pushed them to rethink.

Now, they’re looking at other ways to bring in revenue while still sticking to their promise not to raise income tax for working people.

BBC apologizes to Trump

The BBC has issued an apology to former US President Donald Trump after a Panorama documentary edited his January 6, 2021, speech in a way that made it look like he was urging violence.

BBC Chair Samir Shah called it an “error of judgment,” admitting that parts of Trump’s speech were spliced together in a misleading way.

But while the BBC is saying sorry, it’s not giving in to Trump’s demand for compensation. The broadcaster says there’s no basis for a defamation claim.

Trump’s legal team, however, isn’t letting it go; they’re still pushing for a full retraction, a formal apology, and damages. They’ve even threatened a $1 billion lawsuit if the BBC doesn’t comply.

Novo Nordisk approves new chair

Novo Nordisk shareholders have officially signed off on Lars Rebien Sørensen becoming the company’s new board chair at an extraordinary meeting.

Sørensen, who used to be CEO and now chairs the Novo Nordisk Foundation, will be wearing both hats going forward, which many see as a clear sign of tight alignment between the company and its biggest shareholder.

The shake-up didn’t stop there. Cees de Jong was chosen as vice chair, and two new board members, Britt Meelby Jensen and Stephan Engels, were brought in.

A few minority investors did voice concerns about how much influence the Foundation now has and whether the board is moving too quickly, especially with competition heating up in the obesity drug space.

Still, the changes sailed through with strong backing: more than 93% of shareholders voted in favor of the new board lineup.

The post Europe bulletin: US-Swiss trade deal, UK tax U-turn, Novo Nordisk shake-up appeared first on Invezz

DynamicTradesToday

DynamicTradesToday

Next Post
US-Switzerland trade deal: tariffs slashed to 15%, boosting pharma and watches

US-Switzerland trade deal: tariffs slashed to 15%, boosting pharma and watches

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.







    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.




    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recommended

    Top catalysts to move the SCHD and JEPI ETFs this week

    Top catalysts to move the SCHD and JEPI ETFs this week

    4 months ago
    UFC Champion Conor McGregor Urges Ireland to Adopt Bitcoin Strategic Reserve

    UFC Champion Conor McGregor Urges Ireland to Adopt Bitcoin Strategic Reserve

    7 months ago

    Popular News

      Disclaimer: DynamicTradesToday.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
      The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

      Copyright © 2025 Dynamic Trades Today. All Rights Reserved.

      • About us
      • Contact us
      • Privacy Policy
      • Terms & Conditions
      No Result
      View All Result
      • About us
      • Contact us
      • Home
      • Privacy Policy
      • Terms & Conditions
      • Thank you

      Copyright © 2023 DynamicTradesToday. All Rights Reserved.